SCHEMBL6690286

SCHEMBL6690286

O=P(O)(O)OC1CCCO1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
INPP5A Q14642 3/20 0.35
SMPD1 P17405 1/20 0.34
NOS2 P35228 1/20 0.34
ITPR3 Q14573 7/20 0.33
ITPR2 Q14571 3/20 0.33
ITPR1 Q14643 3/20 0.33
ANPEP P15144 1/20 0.33
INPPL1 O15357 1/20 0.32
AKT1 P31749 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26919943 0.94 INPP5A (0.38) INPP5ASMPD1ITPR3ITPR2ITPR1
SCHEMBL25642458 0.94 INPP5A (0.38) INPP5ASMPD1ITPR3ITPR2ITPR1
SCHEMBL29167358 0.89
SCHEMBL5961173 0.82 GAA (0.33) GAASMN1; SMN2
SCHEMBL30861825 0.80 ALDH1A1 (0.31) ANPEPSMN1; SMN2
SCHEMBL24511964 0.79 MVD (0.33) INPP5A
SCHEMBL28378095 0.76 MEN1 (0.33)
SCHEMBL30473353 0.75
SCHEMBL9320444 0.74
SCHEMBL30223384 0.74 INPP5A (0.36) INPP5ASMPD1ITPR3ITPR2ITPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087164-A1 8-NITRO-TRYPTANTHRIN AND OTHER TRYPTANTHRIN DERIVATIVES USED FOR THE TREATMENT OF DISEASES CAUSED BY HIGHLY PROLIFERATING CELLS UNIVERSITÄTSKLINIKUM CHARITÉ DER HUMBOLDT-UNIVERSITÄT ZU BERLIN (DE) 2004-10-14 WO claimed
CN-110869544-B Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-03-08 CN disclosed
WO-2004087164-A1 8-NITRO-TRYPTANTHRIN AND OTHER TRYPTANTHRIN DERIVATIVES USED FOR THE TREATMENT OF DISEASES CAUSED BY HIGHLY PROLIFERATING CELLS UNIVERSITÄTSKLINIKUM CHARITÉ DER HUMBOLDT-UNIVERSITÄT ZU BERLIN (DE) 2004-10-14 WO disclosed